Replies to post #74861 on GoodFellas Big Board Catalyst and Chart Plays

[SamsaricSufferer]

DRRX +14%




PTIE +35.8%




Two biotechs up on bullish SA article by Red Acre Investments

Both drugs soared when Pfizer revealed it was evaluating of their pain drug Remoxy on April 30th. Then fell on subsequent news from PFE that there was still significant regulatory hurdles to overcome. Still room to run if you look at how the charts mirror each other. as they are both based on the same event, evaluation of their pain drug Remoxy.

http://www.bloomberg.com/news/2013-04-30/pain-therapeutics-durect-jump-as-pfizer-highlights-remoxy-drug.html?

http://www.bloomberg.com/news/2013-05-10/pain-therapeutics-durect-fall-as-pfizer-evaluates-pill.html?